ScienceDex / Researcher record
Anjana Rao
- La Jolla Institute for Immunology (no department on record)
From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.
- Program Leader
- R01 Holder
- Top 10% Funded
- Early Career
- Diverse Portfolio
NIH Funding · FY2024
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $4,514,040 | 8 | #1,326 |
| 2025 | $4,811,437 | 4 | #1,490 |
| 2026 | $2,686,685 | 3 | #7,137 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2024 · selected8 records
- FY20254 records
- FY20263 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 1890226Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0002-1870-1775Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2024 award records by amount
NIH award records listing Anjana Rao as a PI. Multi-PI records show the full award amount for context.
- 2R35CA210043-08A1R35Contact PIThe TET-DNMT-ASXL1-OGT axis: relevance to clonal hematopoiesis, heterochromatin integrity and cancer$1.1Maward amount
- 5R01AI109842-36R01Co-investigatorNFAT, bZIP proteins, and transcriptional programs in lymphocytes$842.4Kaward amount
- 1U01AI180152-01U01Contact PIDysregulation of TET dioxygenase function as a source of aberrant transposable element expression during human aging$658.8Kaward amount
- 5R01AI040127-32R01Co-investigatorSignal transduction and gene induction in lymphocytes$658.8Kaward amount
- 5R01AI128589-08R01Contact PIInvestigating the role of TET deficiency in promoting T cell expansion and inflammation$549Kaward amount
- 5R01CA247500-05R01Contact PIExploring the potential of TET inhibition in cancer immunotherapy$477.5Kaward amount
- 3R01AI128589-08S1R01Contact PIInvestigating the role of TET deficiency in promoting T cell expansion and inflammation$130.2Kaward amount
- 3R01CA247500-05S1R01Contact PIExploring the potential of TET inhibition in cancer immunotherapy$99.4Kaward amount
Award organization
Organizations that administered FY2024 awards listing Anjana Rao as a PI.
FY2024 award administered by La Jolla Institute for Immunology (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardLa Jolla Institute for Immunology
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #1326
- 2024Entered Top 25% NationallyRanked #1326
- 2024Entered Top 10% NationallyRanked #1326
- 2025$5M Cumulative Funding
- 2025R01 Grant Holder
- 2025Program/Center Grant Leader
- 2026$10M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Anjana Rao.